10-K: GBT Technologies Inc. Reports Full Year 2023 Results, Outlines Strategic Shift Towards Microchip Technology

GBT Technologies Inc. reports a net loss of $17.7 million for 2023, while focusing on developing its intellectual property portfolio in microchip technology and strategic partnerships.

Summary

• GBT Technologies Inc. reported a net loss of $17.7 million for the year ended December 31, 2023, compared to a net income of $5.3 million in 2022.
• The company's operating expenses decreased by 37% to $1.7 million in 2023, primarily due to reduced marketing, general, and professional expenses.
• Other expenses increased significantly to $15.9 million in 2023, driven by changes in fair value of derivative liabilities and interest expenses.
• The company's cash flow from operations was negative $51,342 in 2023, and it had a working capital deficit of $31.7 million.
• GBT Technologies is shifting its focus towards developing intellectual property in microchip technology and seeking strategic partnerships.
• The company's 50% owned subsidiary, GBT Tokenize, is developing a vital device and other technologies, and has entered into its first commercial transaction.
• GBT Technologies assigned its entire IP portfolio to GBT Tokenize in 2023.
• The company has active investments in VisionWave, Avant, and MetAlert, with VisionWave acquiring patents for $30 million in stock.
• The company terminated its revenue sharing agreement with Mahaser Ltd. in July 2023.
• The company has 3 full-time and 1 part-time employees as of December 31, 2023.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with a significant net loss and negative cash flow. While there are some positive developments in terms of strategic shifts and partnerships, the overall sentiment is negative due to the company's financial struggles and reliance on external funding.

Positives

• Operating expenses decreased by 37% year-over-year, indicating cost-cutting measures.
• The company is actively developing its intellectual property portfolio in microchip technology.
• GBT Tokenize, a 50% owned subsidiary, has entered into its first commercial transaction.
• The company has active investments in VisionWave, Avant, and MetAlert, indicating potential for future revenue streams.
• The company has assigned its entire IP portfolio to GBT Tokenize, potentially streamlining operations.

Negatives

• The company experienced a significant net loss of $17.7 million in 2023, a sharp decline from the net income of $5.3 million in 2022.
• Other expenses increased dramatically to $15.9 million in 2023, mainly due to changes in fair value of derivative liabilities and interest expenses.
• The company's cash flow from operations was negative $51,342 in 2023, and it had a working capital deficit of $31.7 million.
• The company terminated its revenue sharing agreement with Mahaser Ltd. in July 2023, which may impact future revenue.
• The company has a limited operating history and faces challenges in an evolving industry.

Risks

• The company has a limited operating history in an evolving industry, making it difficult to evaluate future prospects.
• The COVID-19 outbreak has caused disruptions in development operations and may have additional negative impacts.
• The company has not generated positive cash flow from operations and its ability to do so is uncertain.
• The company will require additional capital to support business growth, which may not be available on acceptable terms.
• There is currently a limited public market for the company's common stock, which could negatively affect its value.
• The company's stock price and trading volume may be volatile, which could result in substantial losses for stockholders.
• The company has not paid dividends in the past and has no immediate plans to pay cash dividends.
• Shares eligible for future sale may adversely affect the market for the company's common stock.
• The company's charter documents and Nevada law may inhibit a takeover that stockholders consider favorable.
• Penny stock regulations may impose certain restrictions on marketability of the company's securities.

Future Outlook

The company intends to continue to make investments to support its business growth and will require additional funds to respond to business challenges, including the need to develop new features and products or enhance existing products, improve its operating infrastructure or acquire complementary businesses and technologies. The company expects that it has sufficient capital sources to maintain operations through the year of 2024. In order to fully implement its business plan, the company will need to raise about $12,000,000.

Management Comments

• Management is currently evaluating the impact of the COVID-19 pandemic on the Company and has concluded that while it is reasonably possible that the virus could have a negative effect on the Companys financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements.
• Management has plans to seek additional capital through some private placement offerings of debt and equity securities.

Industry Context

The company is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks. The company's strategic shift towards microchip technology aligns with the increasing demand for advanced semiconductor solutions.

Comparison to Industry Standards

• The company's financial performance is significantly below industry standards for profitability and cash flow generation.
• The company's reliance on convertible debt and equity financing is not uncommon for early-stage technology companies, but the level of dilution and debt burden is concerning.
• The company's strategic shift towards microchip technology is a positive move, but it will require significant investment and execution to compete with established players.
• The company's joint venture with GBT Tokenize is a positive step, but it is still early in its development and commercialization phase.
• The company's active investments in VisionWave, Avant, and MetAlert are promising, but their success is not guaranteed.
• The company's termination of the revenue sharing agreement with Mahaser Ltd. is a setback, but it may allow the company to focus on its core business.

Legal Proceedings

• The company is involved in various litigation matters, but management does not believe they will have a material impact on the financial position of the company.
• The company is involved in a lawsuit with Terry Taylor and TTSG Holdings, Inc for breach of contract, breach of covenant of Good Faith and Fair Dealing, Unjust Enrichment and declaratory relief for failure of providing consulting services per contract they entered.
• The company is involved in a lawsuit with Gregory Mancuso and Rainer AG, a Swiss corporation, for conversion, unjust enrichment, breach of contract, and breach of implied covenant of fair dealing.

Related Party Transactions

• The company has a note payable to Alpha Eda, LLC, a related party, for $140,000.
• The company has a convertible note payable to Stanley Hills LLC, a related party, for $661,395.
• The company has an outstanding payable to Stanley Hills of $835,933.
• The company has $625,000 owed to Yello Partners, Inc., a company owned by the CEO.

Stakeholder Impact

• Shareholders may experience significant volatility in the market price of the company's stock and have difficulty selling their shares.
• Employees may be affected by the company's financial struggles and potential restructuring.
• Customers may be impacted by the company's strategic shift and potential changes in product offerings.
• Suppliers and creditors may be concerned about the company's ability to meet its obligations.

Next Steps

• The company will continue to develop its intellectual property portfolio in microchip technology.
• The company will seek strategic partnerships to commercialize its technologies.
• The company will seek additional capital through private placement offerings of debt and equity securities.
• The company will continue to evaluate the impact of the COVID-19 pandemic on its operations.

Key Dates

Keywords

microchip technology, intellectual property, joint venture, wireless mesh networks, artificial intelligence, IoT, derivative liability, convertible notes, financial results, strategic partnerships